Clinical trial
The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of…
NCT00468260 · Novartis Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00468260 |
|---|---|
| Title | The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies |
| Official title | An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies-extension Study |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Malignancies |
| Intervention type | Drug |
| Interventions | Patupilone |
| Enrollment | 12 |
| Start date | May 1, 2007 |
| First posted | May 2, 2007 |
| Last update posted | Nov 19, 2009 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: